These findings dont rule out its use, but they do mean close monitoring matters, especially if you already have heart disease or risk factors
Are these medications safe for long-term use
If anything, youll find your appetite and cravings are suppressed at just the right amount
The regulatory crackdown on compounding may improve access for some, but it doesn't address the broader issue: keeping patients on these medications long-term requires infrastructure that most telehealth models werent built to provide
There are multiple ongoing phase III studies to investigate survodutide for treatment of obesity, diabetes, cardiovascular disease, and chronic kidney disease
Supporting this, in a phase 2a trial in people with MASLD, the dual GLP-1/GCG agonist efinopegdutide (10 mg) reduced liver fat by 72.7%, compared to 42.3% with semaglutide (1 mg) despite similar WLindicating potential weight-independent effects of GCG on hepatic steatosis [40]